Fainardi E., Castellazzi M., Bellini T., Manfrinato MC, Baldi E., Casetta I. et al. Cerebrospinal fluid and serum levels and intrathecal production ofl active matrix metalloproteinase-9 (MMP-9) as markers ofl disease activity in patients with multiple sclerosis. Mult Scler2006; 12: 294-301.
Rouy D., Ernens I., Jeanty C., Wagner DRPlasma storage at -80 degrees C does not protect matrix metalloproteinase-9 flrom degradation. Anal Biochem2005; 338: 294-98.
Sheu JR, Fong TH, Liu CM, Shen MY, Chen TL, Chang Y. et al. Expression ofl matrix metalloproteinase-9 in human platelets: regulation ofl platelet activation in in vitro and in in vivo studies. Br J Pharmacol2004; 143: 193-201.
8.
Sawicki G., Salas E., Murat J., Miszta-Lane H., Radomski MWRelease ofl gelatinase A during platelets activation mediates aggregation . Nature1997; 386: 616-19.
9.
Freedman MS, Thompson EJ, Deisenhammer F., Giovannoni G., Grimsley G., Keir G. et al. Recommended standard ofl cerebrospinal fluid analysis in the diagnosis ofl multiple sclerosis. A Consensus Statement. Arch Neurol2005; 62: 865-70.
10.
Verspaget HW , Kuyvenhoven JP, van Hock B.Preanalytical conditions and circulating matrix metalloproteinases. Transplantation2005; 79: 745-46.